StopDown
Funding · 14 February 2026BabyOrgano₹20 CrHerbal baby care brand

BabyOrgano raises ₹20 Cr from RPSG Group

By · Editor ·

Founded 2020
  • BabyOrgano makes Ayurveda-based baby care products for skin, hair, and immunity
  • It raised ₹20 crore from RPSG Group after appearing on the TV show Ideabaaz
  • Revenue jumped from ₹7.26 crore in FY24 to ₹25.62 crore in FY25

What happened

  • BabyOrgano, a herbal baby care brand, raised ₹20 crore from RPSG Group.
  • The investment came after the founders appeared on the TV show Ideabaaz.
  • The company makes Ayurveda-based products for skin, hair, oral, and bath care.
  • It also sells daily wellness and immunity boosters like Baalprashan drops and Chocvita nutrition.
  • Revenue grew from ₹7.26 crore in FY24 to ₹25.62 crore in FY25.
  • In the current fiscal, it has recorded ₹22 crore and is on track for ₹50 crore by year-end.
  • Sales are 40% direct D2C via its website and 60% through Amazon, FirstCry, and Zepto.

Why it matters

  • The India baby care market is projected to reach $9.5 billion by 2031.
  • The organic segment is growing at 13.6% CAGR, while synthetic products still hold 75.12% of the category.
  • This investment signals growing investor interest in natural baby care brands.

The business

  • BabyOrgano is an R&D-led brand that tests formulations against modern paediatric standards.
  • It manufactures through 5 partners in Ahmedabad.
  • Products include skin, hair, oral, bath care, daily wellness, and immunity boosters.
  • Key products are Baalprashan immunity drops and Chocvita daily nutrition.
  • Revenue was ₹7.26 crore in FY24 and ₹25.62 crore in FY25.
  • It is on track for ₹50 crore topline by end of FY26.

The founders

Riddhi Sharma

Co-founder
  • Co-founder of BabyOrgano.
  • Husband-wife duo with Ripul Sharma.

Ripul Sharma

Co-founder
  • Co-founder of BabyOrgano.
  • Husband-wife duo with Riddhi Sharma.

Who put in money

  • RPSG Group lead — An Indian business conglomerate with interests in consumer goods, retail, and technology.

In numbers

₹7.26 CrRevenue FY24
₹25.62 CrRevenue FY25
₹22 CrRevenue current fiscal (recorded) · FY26
₹50 CrRevenue target FY26
40%Direct D2C sales share
60%Marketplace sales share

What happens next

  • Transition from a product brand to a service-integrated wellness ecosystem in 12-18 months.
  • Rebrand and launch doctor consultation services.
  • Expand physical footprint via school outreach programmes and exhibitions.
  • Long-term (3-5 years): global expansion to US and Australia.

Words to know

D2C
Direct-to-consumer, selling products directly to customers without intermediaries.
CAGR
Compound annual growth rate, the average yearly growth rate over a period.
Ayurveda
Traditional Indian system of medicine using natural herbs and ingredients.

The numbers around it

Commerce & Consumer Brands in February 2026: 44 rounds with a disclosed amount, $673 million in all; the biggest was Spinny ($170 Mn). Every sector this year →

Read it as a card in the app

Terms in this story

  • Financial year: An Indian financial year runs from 1 April to 31 March, and it is named after the year it ends. FY26 means April 2025 to March 2026. Startup results for a year arrive months after it closes, so a November 2026 story may still be about FY25.

Everything on BabyOrgano → · All startup news on 14 February 2026 →

Is this BabyOrgano? Get your “Featured on StopDown” badge →